1. Xue, Xiangfei, Ma, Lifang, Zhang, Xiao, Shi, Yi, Wang, Jiayi. . Tumour cells are sensitised to ferroptosis via RB1CC1-mediated transcriptional reprogramming. In Clinical and translational medicine, 12, e747. doi:10.1002/ctm2.747. https://pubmed.ncbi.nlm.nih.gov/35220675/
2. Chen, Pingfeng, Duan, Youjun, Lu, Xinsheng, Hu, Rong, Liu, Shimin. 2021. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation. In Cancer immunology, immunotherapy : CII, 70, 3261-3275. doi:10.1007/s00262-021-02913-8. https://pubmed.ncbi.nlm.nih.gov/33837850/
3. Liang, Jianfeng, Cai, Hongshi, Hou, Chen, Yu, Dongsheng, Hou, Jinsong. . METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner. In Clinical science (London, England : 1979), 137, 1373-1389. doi:10.1042/CS20230219. https://pubmed.ncbi.nlm.nih.gov/37615536/